dihexa hgf/c-met potentiator

dihexa hgf/c-met potentiator HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers Correlation between hypoxia and HGF/c-MET

Name: dihexa hgf/c-met potentiator HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers Correlation between hypoxia and HGF/c-MET
Brand: l2q2.es
SKU: 9933087528
Price: 29.59 USD
Availability: InStock
Rating: 4.2619 (15 reviews)

Correlation between hypoxia and HGF c MET expression in the management of pancreatic cancer ScienceDirect The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic Hepatocyte Growth Factor MET Activator Rescues Working Memory Deficits After Repeated Mild Traumatic Brain Injury bioRxiv Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect

SKU: 9933087528 · From l2q2.es

4.3

USD29.59 USD52.59

Pay in 4 interest-free payments of $7.40 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

Description

Besides, HSPA1, previously known anti-proliferative factor with JAK/STAT pathway involved, is additionally reported to mediate the angiogenic effect of interleukin-28A in vitro and in vivo via the eNOS/AKT signaling pathway and the activator protein-1/nuclear factor-B/matrix metalloproteinase-2 (AP-1/NF-B/MMP-2) cascade (Song et al., 2025)